SG11201707145QA - Pyrrolidine carboxamido derivatives and methods for preparing and using the same - Google Patents
Pyrrolidine carboxamido derivatives and methods for preparing and using the sameInfo
- Publication number
- SG11201707145QA SG11201707145QA SG11201707145QA SG11201707145QA SG11201707145QA SG 11201707145Q A SG11201707145Q A SG 11201707145QA SG 11201707145Q A SG11201707145Q A SG 11201707145QA SG 11201707145Q A SG11201707145Q A SG 11201707145QA SG 11201707145Q A SG11201707145Q A SG 11201707145QA
- Authority
- SG
- Singapore
- Prior art keywords
- preparing
- methods
- same
- carboxamido derivatives
- pyrrolidine
- Prior art date
Links
- -1 Pyrrolidine carboxamido Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150097040 | 2015-07-08 | ||
PCT/US2016/041563 WO2017008033A1 (fr) | 2015-07-08 | 2016-07-08 | Dérivés de carboxamido pyrrolidine et leurs procédés de préparation et d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201707145QA true SG11201707145QA (en) | 2017-10-30 |
Family
ID=57686085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201707145QA SG11201707145QA (en) | 2015-07-08 | 2016-07-08 | Pyrrolidine carboxamido derivatives and methods for preparing and using the same |
Country Status (25)
Country | Link |
---|---|
US (3) | US20170008924A1 (fr) |
EP (1) | EP3265443B1 (fr) |
JP (1) | JP6692371B2 (fr) |
KR (1) | KR101963559B1 (fr) |
CN (2) | CN107531753A (fr) |
AU (1) | AU2016290963B2 (fr) |
BR (1) | BR112017022857B1 (fr) |
CA (1) | CA2980001C (fr) |
CL (1) | CL2017002689A1 (fr) |
CO (1) | CO2017010530A2 (fr) |
DK (1) | DK3265443T3 (fr) |
EA (1) | EA033342B1 (fr) |
ES (1) | ES2784703T3 (fr) |
HK (1) | HK1243078A1 (fr) |
IL (1) | IL254327B (fr) |
MX (1) | MX2017013335A (fr) |
MY (1) | MY189670A (fr) |
NZ (1) | NZ735250A (fr) |
PH (1) | PH12017501790A1 (fr) |
PL (1) | PL3265443T3 (fr) |
PT (1) | PT3265443T (fr) |
SA (1) | SA517390034B1 (fr) |
SG (1) | SG11201707145QA (fr) |
UA (1) | UA121890C2 (fr) |
WO (1) | WO2017008033A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY189670A (en) | 2015-07-08 | 2022-02-24 | Research & Business Found Sungkyunkwan Univ | Pyrrolidine carboxamido derivatives and methods for preparing and using the same |
EP3759070A4 (fr) * | 2018-02-28 | 2021-12-08 | Bridge Biotherapeutics, Inc. | Sels hydrosolubles de peptides lipidés et leurs procédés de préparation et d'utilisation |
SG11202104802RA (en) * | 2018-11-08 | 2021-06-29 | Arizona Board Of Regents On Behalf Arizona State Univ | Synthetic immunomodulation with a crispr super-repressor in vivo |
KR102104507B1 (ko) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법 |
KR102268702B1 (ko) * | 2019-10-17 | 2021-06-24 | 주식회사 에피바이오텍 | Rip 키나아제 억제제를 포함하는 탈모 방지 또는 발모 촉진용 조성물 |
CN114585383B (zh) * | 2019-10-17 | 2024-04-19 | 艾弼生物科技有限公司 | 包含rip激酶抑制剂的用于防脱发或促生发的组合物 |
KR102394875B1 (ko) * | 2021-05-11 | 2022-05-06 | 주식회사 비드테크 | 피롤리딘을 링커로 포함하는 화합물 및 이를 포함하는 약학 조성물 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3839127A1 (de) * | 1988-11-19 | 1990-05-23 | Hoechst Ag | Pyrrolidon-2-carbonsaeure-derivate mit psychotroper wirkung |
AUPM906594A0 (en) | 1994-10-26 | 1994-11-17 | Peptide Technology Limited | Synthetic polyunsaturated fatty acid analogues |
EP1988078B1 (fr) * | 1996-05-01 | 2012-10-17 | Ortho-McNeil Pharmaceutical, Inc. | Dérivés carboxamide de pyrrolidine, pipéridine et hexahydroazépine pour traiter des troubles thrombotiques |
US6114361A (en) * | 1998-11-05 | 2000-09-05 | Pfizer Inc. | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
JP2002297664A (ja) | 2001-04-03 | 2002-10-11 | Fuji Photo Film Co Ltd | 画像データ提供装置および画像データ提供プログラム |
WO2003007876A2 (fr) | 2001-06-25 | 2003-01-30 | University Of Massachusetts | Conjugues acide amine-acide gras normal et utilisations therapeutiques |
DE10259672A1 (de) * | 2002-12-18 | 2004-07-01 | Basf Ag | Verfahren zur Herstellung von Alkoxycarbonylamino-triazinen |
JP2006157623A (ja) * | 2004-11-30 | 2006-06-15 | Funai Electric Co Ltd | 放送受信装置 |
WO2006113942A2 (fr) * | 2005-04-20 | 2006-10-26 | Schering Corporation | Procede d'inhibition de l'activite de cathepsine |
US7842662B2 (en) * | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
KR20100058541A (ko) * | 2007-08-15 | 2010-06-03 | 아뮤닉스 인코포레이티드 | 생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법 |
CN102067197A (zh) | 2008-06-26 | 2011-05-18 | 夏普株式会社 | 显示装置和电子设备 |
CN102123697B (zh) | 2008-08-18 | 2015-06-10 | 安特拉贝欧有限公司 | 用于口服给予蛋白质的方法和组合物 |
KR101033041B1 (ko) | 2008-11-13 | 2011-05-09 | 조선대학교산학협력단 | 경보장치 고정 장치 |
WO2010059922A1 (fr) * | 2008-11-21 | 2010-05-27 | Ligand Pharmaceuticals Incorporated | Composés de pyrrolidine carboxamide |
KR101151878B1 (ko) | 2010-06-08 | 2012-05-31 | 미원상사주식회사 | 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물 |
KR20100110282A (ko) | 2010-08-16 | 2010-10-12 | 황규태 | 쓰레기봉투용 뚜껑 |
KR101348284B1 (ko) * | 2010-09-09 | 2014-01-03 | 주식회사 나이벡 | 인간 유래 세포 투과성 펩타이드와 생리활성 펩타이드 결합체 및 그 용도 |
KR20120048864A (ko) | 2010-11-08 | 2012-05-16 | 주식회사 네오디엠 | 트리 펩타이드 유도체를 함유한 아토피 피부염 예방 및 치료용 조성물과 그 제조방법 |
KR20130038426A (ko) | 2011-10-07 | 2013-04-18 | 성균관대학교산학협력단 | 지방산이 결합된 항당뇨 펩티드가 소수성 결합된 글리콜 키토산 히드로겔 및 이를 포함하는 당뇨병 예방 또는 치료용 약학적 조성물 |
KR101359886B1 (ko) | 2011-12-28 | 2014-02-12 | 성균관대학교산학협력단 | 스매드 6번(Smad6)으로부터 유래된 펩타이드를 유효성분으로 포함하는 패혈증 또는 패혈성 쇼크의 치료용 조성물 |
WO2013190497A2 (fr) * | 2012-06-21 | 2013-12-27 | Radikal Therapeutics Inc. | Compositions et procédés pour le traitement de maladies inflammatoires du poumon |
US20160228569A1 (en) * | 2013-10-15 | 2016-08-11 | S. Kenny Roberts | Peptide constructs and well-defined aggregates thereof |
MY189670A (en) | 2015-07-08 | 2022-02-24 | Research & Business Found Sungkyunkwan Univ | Pyrrolidine carboxamido derivatives and methods for preparing and using the same |
-
2016
- 2016-07-08 MY MYPI2017703626A patent/MY189670A/en unknown
- 2016-07-08 MX MX2017013335A patent/MX2017013335A/es active IP Right Grant
- 2016-07-08 CN CN201680020220.8A patent/CN107531753A/zh active Pending
- 2016-07-08 ES ES16822053T patent/ES2784703T3/es active Active
- 2016-07-08 EA EA201791945A patent/EA033342B1/ru not_active IP Right Cessation
- 2016-07-08 KR KR1020177028207A patent/KR101963559B1/ko active IP Right Grant
- 2016-07-08 DK DK16822053.1T patent/DK3265443T3/da active
- 2016-07-08 BR BR112017022857-2A patent/BR112017022857B1/pt active IP Right Grant
- 2016-07-08 US US15/205,853 patent/US20170008924A1/en not_active Abandoned
- 2016-07-08 PL PL16822053T patent/PL3265443T3/pl unknown
- 2016-07-08 PT PT168220531T patent/PT3265443T/pt unknown
- 2016-07-08 UA UAA201710114A patent/UA121890C2/uk unknown
- 2016-07-08 CA CA2980001A patent/CA2980001C/fr active Active
- 2016-07-08 SG SG11201707145QA patent/SG11201707145QA/en unknown
- 2016-07-08 AU AU2016290963A patent/AU2016290963B2/en active Active
- 2016-07-08 NZ NZ735250A patent/NZ735250A/en unknown
- 2016-07-08 WO PCT/US2016/041563 patent/WO2017008033A1/fr active Application Filing
- 2016-07-08 EP EP16822053.1A patent/EP3265443B1/fr active Active
- 2016-07-08 JP JP2017551335A patent/JP6692371B2/ja active Active
- 2016-07-08 CN CN202210589872.0A patent/CN115368438A/zh active Pending
-
2017
- 2017-09-04 IL IL254327A patent/IL254327B/en active IP Right Grant
- 2017-09-27 SA SA517390034A patent/SA517390034B1/ar unknown
- 2017-09-28 PH PH12017501790A patent/PH12017501790A1/en unknown
- 2017-10-13 CO CONC2017/0010530A patent/CO2017010530A2/es unknown
- 2017-10-23 CL CL2017002689A patent/CL2017002689A1/es unknown
-
2018
- 2018-02-26 HK HK18102699.0A patent/HK1243078A1/zh unknown
- 2018-03-14 US US15/921,596 patent/US11365215B2/en active Active
-
2022
- 2022-08-03 US US17/817,252 patent/US20230018246A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251561A1 (zh) | 吡唑化合物以及製備和使用該化合物的方法 | |
IL259433A (en) | Eif4-a inhibitory compounds and related methods | |
HK1251551A1 (zh) | 氮雜環丁烷衍生物、其製備方法及用途 | |
EP3359168A4 (fr) | Composés thérapeutiques et procédés | |
EP3262022A4 (fr) | Colorants à base de phényléthynylnaphtalène et procédés d'utilisation associés | |
HK1256242A1 (zh) | 吲哚化合物以及製備和使用該化合物的方法 | |
HK1243078A1 (zh) | 吡咯烷酰胺衍生物及其製備和使用方法 | |
IL272924A (en) | Methods for preparing and using endoxifen | |
EP3325712A4 (fr) | Microfibres avancées et procédés associés | |
HK1254456A1 (zh) | 吡咯烷衍生物 | |
EP3384104A4 (fr) | Élément de fixation de chape et ses procédés d'utilisation | |
ZA201804120B (en) | Novel pyrrolidine derivatives | |
EP3344661C0 (fr) | Complexes de fer-polysaccharide et leurs procédés de préparation | |
EP3253732A4 (fr) | 4-azidobutylamines et leurs procédés de production | |
AU2015904275A0 (en) | Connection methods and apparatus | |
AU2015901676A0 (en) | Compounds and Methods |